ATARA BIOTHERAPEUTICS, INC. Interest Receivable
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Interest Receivable of $100.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Assets
us-gaap:InterestReceivable · last filed 2024-11-12
- 2024-09-30: Interest Receivable $100.00K.
- 2024-06-30: Interest Receivable $100.00K.
- 2024-03-31: Interest Receivable $200.00K.
- 2023-12-31: Interest Receivable $300.00K.
| Period end | Interest Receivable | Interest Receivable as first filed |
|---|---|---|
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $200.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $300.00K 10-Q · filed 2024-11-12 | |
| 2023-09-30 | $400.00K 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $400.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $700.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $800.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $800.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $900.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $600.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $800.00K 10-K · filed 2023-02-08 | |
| 2021-09-30 | $800.00K 10-Q · filed 2022-05-05 | $400.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $700.00K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $700.00K 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $700.00K 10-K · filed 2022-02-28 | |
| 2020-09-30 | $800.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $800.00K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $800.00K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $900.00K 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |